Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Scrub Typhus | 5 | 2018 | 68 | 1.22 | Why? |
| Acute Febrile Encephalopathy | 3 | 2018 | 27 | 1.09 | Why? |
| Orientia tsutsugamushi | 4 | 2018 | 45 | 1.00 | Why? |
| India | 34 | 2021 | 11875 | 0.74 | Why? |
| Strategic Planning | 1 | 2020 | 122 | 0.74 | Why? |
| Sentinel Surveillance | 4 | 2020 | 1093 | 0.72 | Why? |
| Containment of Biohazards | 1 | 2020 | 762 | 0.52 | Why? |
| Rubella virus | 3 | 2019 | 46 | 0.42 | Why? |
| Laboratories | 3 | 2021 | 2858 | 0.37 | Why? |
| Clinical Laboratory Techniques | 6 | 2020 | 23402 | 0.34 | Why? |
| Rubella | 2 | 2019 | 127 | 0.33 | Why? |
| Mass Screening | 2 | 2021 | 8005 | 0.25 | Why? |
| Dengue | 4 | 2019 | 1565 | 0.24 | Why? |
| Pneumonia, Viral | 13 | 2020 | 243684 | 0.21 | Why? |
| Coronavirus Infections | 13 | 2020 | 253789 | 0.21 | Why? |
| Disease Outbreaks | 7 | 2019 | 27595 | 0.21 | Why? |
| Encephalitis, Japanese | 2 | 2018 | 58 | 0.21 | Why? |
| Distemper Virus, Canine | 1 | 2019 | 40 | 0.20 | Why? |
| Lions | 1 | 2019 | 41 | 0.20 | Why? |
| Topography, Medical | 1 | 2019 | 45 | 0.20 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2020 | 13720 | 0.20 | Why? |
| Vaccines, Inactivated | 3 | 2021 | 1562 | 0.19 | Why? |
| Rubella Syndrome, Congenital | 1 | 2018 | 17 | 0.19 | Why? |
| Real-Time Polymerase Chain Reaction | 5 | 2020 | 11367 | 0.18 | Why? |
| Nipah Virus | 1 | 2019 | 121 | 0.18 | Why? |
| Hepatitis A virus | 1 | 2018 | 68 | 0.18 | Why? |
| Hepatitis Antibodies | 1 | 2018 | 100 | 0.18 | Why? |
| Infectious Encephalitis | 1 | 2017 | 20 | 0.18 | Why? |
| Public Sector | 1 | 2020 | 204 | 0.17 | Why? |
| Diagnostic Tests, Routine | 2 | 2020 | 2643 | 0.17 | Why? |
| Henipavirus Infections | 1 | 2019 | 122 | 0.17 | Why? |
| Primates | 1 | 2021 | 584 | 0.17 | Why? |
| Eligibility Determination | 1 | 2020 | 255 | 0.17 | Why? |
| Cost of Illness | 2 | 2019 | 1903 | 0.17 | Why? |
| Haemophilus influenzae | 1 | 2018 | 196 | 0.17 | Why? |
| Encephalitis Virus, Japanese | 1 | 2017 | 63 | 0.17 | Why? |
| Animal Diseases | 1 | 2019 | 182 | 0.17 | Why? |
| Meningitis, Bacterial | 1 | 2018 | 111 | 0.16 | Why? |
| Phylogeography | 1 | 2021 | 824 | 0.16 | Why? |
| Automation, Laboratory | 1 | 2020 | 536 | 0.16 | Why? |
| Infant | 8 | 2020 | 30274 | 0.16 | Why? |
| Hepatitis A | 1 | 2018 | 140 | 0.16 | Why? |
| Neisseria meningitidis | 1 | 2018 | 229 | 0.16 | Why? |
| Hospitals, Special | 1 | 2021 | 523 | 0.15 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.15 | Why? |
| Quality Control | 1 | 2020 | 628 | 0.15 | Why? |
| Child, Preschool | 8 | 2020 | 36283 | 0.15 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.15 | Why? |
| Sewage | 1 | 2021 | 591 | 0.15 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.14 | Why? |
| Hepatitis E virus | 1 | 2018 | 306 | 0.14 | Why? |
| Chiroptera | 2 | 2020 | 3530 | 0.14 | Why? |
| Betacoronavirus | 13 | 2020 | 204454 | 0.13 | Why? |
| Community Participation | 1 | 2021 | 605 | 0.13 | Why? |
| Specimen Handling | 3 | 2021 | 6190 | 0.13 | Why? |
| Hepatitis E | 1 | 2018 | 319 | 0.13 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.12 | Why? |
| Dengue Virus | 2 | 2017 | 910 | 0.12 | Why? |
| Adolescent | 12 | 2021 | 86841 | 0.12 | Why? |
| Child | 10 | 2021 | 70012 | 0.12 | Why? |
| Infant, Newborn | 5 | 2020 | 23105 | 0.12 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2021 | 7868 | 0.11 | Why? |
| Central Nervous System | 1 | 2017 | 701 | 0.11 | Why? |
| Government | 1 | 2021 | 1453 | 0.11 | Why? |
| Genome, Viral | 4 | 2021 | 13157 | 0.11 | Why? |
| Humans | 41 | 2021 | 930598 | 0.11 | Why? |
| High-Throughput Screening Assays | 1 | 2020 | 1783 | 0.11 | Why? |
| Disease Susceptibility | 2 | 2020 | 4002 | 0.10 | Why? |
| Immunoglobulin M | 4 | 2019 | 9091 | 0.09 | Why? |
| Young Adult | 10 | 2021 | 93724 | 0.09 | Why? |
| High-Throughput Nucleotide Sequencing | 4 | 2021 | 3633 | 0.09 | Why? |
| Reagent Kits, Diagnostic | 1 | 2019 | 2149 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.08 | Why? |
| Female | 21 | 2021 | 380317 | 0.08 | Why? |
| Pandemics | 15 | 2021 | 389249 | 0.08 | Why? |
| Antibodies, Viral | 7 | 2021 | 51949 | 0.08 | Why? |
| Male | 19 | 2021 | 367725 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.07 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.07 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.07 | Why? |
| Pregnancy Complications, Infectious | 3 | 2019 | 11559 | 0.07 | Why? |
| Antibodies, Neutralizing | 8 | 2021 | 25288 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.07 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.07 | Why? |
| Adult | 12 | 2021 | 244371 | 0.06 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.06 | Why? |
| Epidemiological Monitoring | 3 | 2021 | 3493 | 0.06 | Why? |
| Pharynx | 2 | 2020 | 1544 | 0.06 | Why? |
| Seasons | 3 | 2019 | 4071 | 0.06 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.05 | Why? |
| Toll-Like Receptor 8 | 1 | 2021 | 102 | 0.05 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.05 | Why? |
| Tanzania | 1 | 2021 | 294 | 0.05 | Why? |
| Fever | 1 | 2017 | 7795 | 0.05 | Why? |
| Animals | 8 | 2021 | 78931 | 0.05 | Why? |
| Double-Blind Method | 2 | 2021 | 5988 | 0.05 | Why? |
| Turbinates | 1 | 2020 | 205 | 0.05 | Why? |
| Aged | 6 | 2021 | 215776 | 0.05 | Why? |
| Rickettsia Infections | 1 | 2018 | 58 | 0.05 | Why? |
| Seroepidemiologic Studies | 3 | 2020 | 10017 | 0.05 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| Public-Private Sector Partnerships | 1 | 2021 | 259 | 0.04 | Why? |
| Microscopy, Electron, Transmission | 1 | 2020 | 605 | 0.04 | Why? |
| Leptospira | 1 | 2017 | 48 | 0.04 | Why? |
| Phylogeny | 3 | 2021 | 13341 | 0.04 | Why? |
| Th2 Cells | 1 | 2021 | 680 | 0.04 | Why? |
| Toll-Like Receptor 7 | 1 | 2021 | 402 | 0.04 | Why? |
| Drinking Water | 1 | 2018 | 145 | 0.04 | Why? |
| State Government | 1 | 2021 | 416 | 0.04 | Why? |
| Pregnancy | 4 | 2019 | 23879 | 0.04 | Why? |
| Spleen | 1 | 2020 | 877 | 0.04 | Why? |
| Rectum | 1 | 2019 | 495 | 0.04 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.04 | Why? |
| Trachea | 1 | 2020 | 894 | 0.04 | Why? |
| Culicidae | 1 | 2016 | 239 | 0.04 | Why? |
| Th1 Cells | 1 | 2021 | 1228 | 0.03 | Why? |
| Federal Government | 1 | 2021 | 562 | 0.03 | Why? |
| Doxycycline | 1 | 2017 | 307 | 0.03 | Why? |
| Insect Vectors | 1 | 2016 | 227 | 0.03 | Why? |
| Sanitation | 1 | 2018 | 403 | 0.03 | Why? |
| Nasal Cavity | 1 | 2020 | 909 | 0.03 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.03 | Why? |
| Genes, Viral | 1 | 2019 | 1428 | 0.03 | Why? |
| Advisory Committees | 1 | 2021 | 1418 | 0.03 | Why? |
| Sequence Alignment | 1 | 2020 | 2109 | 0.03 | Why? |
| Spatial Analysis | 1 | 2019 | 878 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2021 | 2275 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Patient Acuity | 1 | 2020 | 1755 | 0.03 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.03 | Why? |
| Communicable Diseases, Imported | 1 | 2021 | 843 | 0.03 | Why? |
| Cricetinae | 1 | 2020 | 3344 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Feasibility Studies | 1 | 2021 | 3467 | 0.03 | Why? |
| Travel | 2 | 2020 | 7220 | 0.03 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.03 | Why? |
| South Africa | 1 | 2021 | 3326 | 0.03 | Why? |
| Cost-Benefit Analysis | 1 | 2021 | 2259 | 0.03 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.03 | Why? |
| Follow-Up Studies | 2 | 2021 | 17020 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2020 | 5814 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2020 | 5542 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.02 | Why? |
| Urban Population | 1 | 2019 | 2000 | 0.02 | Why? |
| Public Policy | 1 | 2021 | 1894 | 0.02 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.02 | Why? |
| Health Surveys | 1 | 2019 | 2841 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Iran | 1 | 2020 | 5467 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Rural Population | 1 | 2019 | 2408 | 0.02 | Why? |
| Kidney | 1 | 2020 | 3648 | 0.02 | Why? |
| Italy | 2 | 2020 | 38444 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.02 | Why? |
| Pregnant Women | 1 | 2018 | 2535 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.02 | Why? |
| Emergencies | 1 | 2020 | 4095 | 0.02 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.02 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2019 | 53120 | 0.01 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| Mice | 1 | 2020 | 21357 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Hospitals | 1 | 2019 | 11793 | 0.01 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.01 | Why? |
Gupta's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(192)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(241)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_